Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$876K Buy
14,176
+12,309
+659% +$810K ﹤0.01% 969
2021
Q2
$158K Buy
+1,867
New +$170K ﹤0.01% 1368
2019
Q4
Sell
-6,525
Closed -$192K 1260
2019
Q3
$192K Buy
+6,525
New +$194K ﹤0.01% 963

Other funds holding AFMD

Marshall Wace North America's AFMD Position: Q3 2021 in Review

Marshall Wace North America increased its Affimed (AFMD) stake by 659% in Q3 2021, buying an estimated $810K and bringing the position to 14,176 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

Marshall Wace North America first reported a position in AFMD in Q3 2019 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold AFMD as of Q3 2021.

  • Marshall Wace North America held 14,176 shares of Affimed worth $876K as of Q3 2021.
  • Marshall Wace North America bought 12,309 Affimed shares in Q3 2021, an estimated $810K.
  • Affimed made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #969 holding.
  • Marshall Wace North America first reported a position in Affimed in Q3 2019 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Affimed as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.